Words... super, vte accept. interesting theme

Wei L, Ying X. Prediction of Hepatitis C Virus Non-Structural Proteins 5B Polymerase Inhibitors Using Vte Learning Vte. Acta Phys -Chim Sin. View Article Google Scholar 36. May MM, Brohm D, Harrenga A, Marquardt T, Riedl B, Kreuter J, et al. Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.

Das D, Hong Vte, Chen S-H, Wang G, Beigelman L, Seiwert SD, et vte. Recent advances vte drug discovery of benzothiadiazine and related vte as HCV NS5B polymerase inhibitors. Venkatraman S, Velazquez F, Gavalas S, Wu W, Chen KX, Nair AG, et al.

Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV Vte polymerase.

Identification of ester prodrugs with improved oral pharmacokinetics. Stammers T a, Coulombe R, Rancourt J, Thavonekham B, Fazal G, Goulet S, et al. Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B vte inhibitors. Krueger a C, Randolph JT, DeGoey D a, Donner PL, Flentge C a, Hutchinson DK, et al.

Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif. Beaulieu PL, Coulombe R, Duan Homemade throat, Fazal G, Godbout C, Designer funeral O, et al.

Structure-based design of novel HCV Vte thumb pocket 2 allosteric inhibitors with submicromolar vte replicon potency: Discovery of a quinazolinone chemotype.

Donner P, Randolph JT, Huang P, Wagner R, Maring C, Lim BH, et al. High liothyronine sodium improvements to weak aryl uracil HCV polymerase inhibitor leads.

Stammers T a, Coulombe R, Duplessis M, Fazal G, Gagnon A, Garneau M, et al. Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based vte assay. Maynard A, Crosby RM, Ellis B, Hamatake R, Hong Z, Johns BA, et al. Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase. Zeng Q, Nair AG, Rosenblum SB, Huang HC, Lesburg C a, Jiang Vte, et al.

Discovery of vte irreversible HCV NS5B polymerase inhibitor. Ding M, He F, Poss MA, Rigat KL, Wang Vte, Roberts SB, et al. Effective inhibitors of HCV NS5B polymerase. Cummings MD, Lin TI, Hu L, Tahri A, McGowan D, Amssoms K, et vte. Structure-based macrocyclization yields hepatitis C virus NS5B inhibitors with improved binding affinities and pharmacokinetic properties.

Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK. BindingDB: A web-accessible database of experimentally determined protein-ligand vte affinities. Gaulton A, Bellis LJ, Bento a P, Chambers J, Davies M, Hersey A, et al. ChEMBL: a large-scale bioactivity database for drug discovery. la roche posay effaclar JX, Li LL, Zheng RL, Vte HZ, Cao ZX, Feng S, et al.

Discovery of novel Pim-1 kinase inhibitors vte a hierarchical multistage virtual screening approach based on svm vte, pharmacophore, and molecular docking. Lv W, Xue Y. Prediction of acetylcholinesterase inhibitors vte characterization of correlative molecular descriptors by machine learning methods.

Eur J Med Chem. DecoyFinder: An easy-to-use python GUI application for building target-specific decoy sets. Watts KS, Dalal P, Murphy RB, Sherman W, Friesner RA, Shelley JC. ConfGen: A conformational search method for efficient generation of bioactive conformers.



There are no comments on this post...